Related Experiment Video
Updated: May 7, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Study of the hepatitis C virus in the republic of macedonia
S Kiprijanovska1, E Sukarova-Stefanovska, P Noveski
1Research Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov," Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia.
Insights
Hepatitis C virus (HCV) infection prevalence in Macedonia is low in the general population but high in at-risk groups. Specific HCV genotypes correlate with risk factors, and OASL gene variations may predict treatment response.
Area of Science:
- Virology
- Hepatology
- Genetics
Background:
- Hepatitis C virus (HCV) poses a significant global health challenge, leading to chronic liver disease and necessitating liver transplantation.
- Current HCV eradication therapies exhibit variable success rates (50-80%), heavily influenced by the specific HCV genotype.
- Molecular detection of HCV in the Republic of Macedonia commenced in 1990, with extensive analysis conducted at the Research Centre for Genetic Engineering and Biotechnology.
Purpose of the Study:
- To determine the prevalence of HCV infections and characterize genotypes within the Republic of Macedonia.
- To investigate the association between HCV genotypes and specific risk factors in infected patients.
- To explore the relationship between polymorphisms in the Oligoadenylate synthetase (OASL) gene and sustained virological response to HCV treatment.
Main Methods:
- Analysis of over 4000 patient samples for molecular detection and characterization of HCV.
- Prevalence studies in the general and at-risk populations, including hemodialysis patients and intravenous drug users.
- Genotyping of HCV and statistical analysis of six polymorphisms in the OASL gene for association with treatment outcomes.
Main Results:
- HCV prevalence in the general Macedonian population is 0.4%, contrasting with 23-43% in at-risk groups.
- HCV genotype 1 is predominant in hemodialysis patients, while genotype 3 is prevalent in intravenous drug users.
- Preliminary findings indicate an association between non-ancestral alleles in four OASL gene polymorphisms and sustained virological response in HCV-infected patients.
Conclusions:
- HCV epidemiology in the Republic of Macedonia shows distinct genotype prevalence based on risk factors.
- OASL gene polymorphisms present a potential predictive marker for sustained virological response in HCV treatment.
- Further research is warranted to validate these genetic associations and their clinical implications for HCV management.
Abstract:
Hepatitis C virus (HCV) is a major public health problem. It is a leading cause of chronic liver disease and the most common indication for liver transplantation. The therapy for eradication of HCV infection is successful in only 50.0-80.0% of patients and is highly dependent on the HCV genotype. Molecular detection and characterization of HCV in the Republic of Macedonia started in 1990. Since then, more than 4000 samples have been analyzed at the Research Centre for Genetic Engineering and Biotechnology (RCGEB) "Georgi D. Efremov," Skopje, Republic of Macedonia. The prevalence of HCV infections in the healthy population of the Republic of Macedonia was found to be 0.4%, while it varies between 23.0 and 43.0% in different at-risk groups of patients. The prevalence of HCV genotypes, according to associated risk factors in HCV infected patients from the Republic of Macedonia, was analyzed. We found genotype 1 to be predominant in a group of hemodialysis patients, while genotype 3 was predominant in intravenous (IV) drug users. Association of six polymorphisms in the Oligoadenylate synthetase (OASL)-like interferon-stimulated gene with a sustained virological response was also analyzed. Our preliminary results suggest that non ancestral alleles in four of the six studies polymorphisms in OASL gene are associated with sustained virological response among HCV infected patients in R. Macedonia.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease

